Related Experiment Videos
Insights
Low plasma chromium levels are observed in coronary artery disease patients. This chromium deficiency may be a primary risk factor for cardiovascular disease due to impaired metabolism and elevated insulin levels.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Nutritional Science
Background:
- Plasma chromium levels are significantly lower in patients with coronary artery disease (CAD) compared to healthy individuals.
- Chromium, also known as glucose tolerance factor (GTF), plays a role in physiological functions linked to cardiovascular risk factors.
- Existing literature suggests chromium's involvement in managing insulin levels and activities.
Purpose of the Study:
- To investigate the potential link between chromium deficiency and coronary artery disease.
- To explore the role of chromium in lipid and glucide metabolism concerning cardiovascular health.
- To determine if chromium deficiency could be a primary risk factor for cardiovascular disease.
Main Methods:
- Review of existing literature on chromium's physiological functions and cardiovascular risk factors.
- Analysis of recent measurements comparing plasma chromium levels in CAD patients and normal subjects.
- Correlation analysis between chromium levels, insulin activity, and metabolic parameters.
Main Results:
- Patients with coronary artery disease exhibit markedly lower plasma chromium levels than normal subjects.
- Chromium deficiency is associated with impaired lipid and glucide metabolism.
- Chromium deficiency leads to elevated circulating insulin levels.
Conclusions:
- Chromium deficiency may represent a primary risk factor for cardiovascular disease.
- The observed effects on metabolism and insulin levels suggest a significant role for chromium in cardiovascular health.
- Further research is warranted to elucidate the direct causal relationship and therapeutic implications.
Abstract:
Recent measurements have demonstrated that plasma chromium levels in patients with coronary artery disease are very much lower than in normal subjects. A review of the literature concerning the physiological functions of chromium (or GTF) shows it to be implicated in most of the known factors of cardiovascular risk, via its effect on insulin levels and activities. Chromium deficiency leads to impaired lipid and glucide metabolism and results in high circulating insulin levels, the probable consequences of which suggest that chromium deficiency may be a primary risk factor in cardiovascular disease.